OBJECTIVE: To determine the prophylactic capability of anterior cruciate ligament (ACL) reconstruction in decreasing the risk of knee osteoarthritis (OA) when compared with ACL-deficient patients, as well as the effect of a concomitant meniscectomy. We also sought to examine the influence of study design, publication date, and graft type as well as the magnitude of change in physical activity from preinjury Tegner scores in both cohorts. DATA SOURCES: We searched Web of Science and PubMed databases from 1960 through 2012 with the search terms osteoarthritis, meniscectomy, anterior cruciate ligament, anterior cruciate ligament reconstruction, and anterior cruciate ligament deficient. STUDY SELECTION: Articles that reported the prevalence of tibiofemoral or patellofemoral OA based on radiographic assessment were included. We calculated numbers needed to treat and relative risk reduction with associated 95% confidence intervals for 3 groups (1) patients with meniscal and ACL injury, (2) patients with isolated ACL injury, and (3) total patients (groups 1 and 2). DATA EXTRACTION: A total of 38 studies met the criteria. Of these, 27 assessed the presence of tibiofemoral osteoarthritis in patients treated with anterior cruciate ligament reconstruction. DATA SYNTHESIS: Overall, ACL reconstruction (ACL-R) yielded a numbers needed to treat to harm of 16 with a relative risk increase of 16%. Anterior cruciate ligament reconstruction along with meniscectomy yielded a numbers needed to treat to benefit of 15 and relative risk reduction of 11%. Isolated ACL-R showed a numbers needed to treat to harm of 8 and relative risk increase of 43%. Activity levels were decreased in both ACL-R (d = -0.90; 95% confidence interval = 0.77, 1.13) and ACL-deficient (d = -1.13; 95% confidence interval = 0.96, 1.29) patients after injury. CONCLUSIONS: The current literature does not provide substantial evidence to suggest that ACL-R is an adequate intervention to prevent knee osteoarthritis. With regard to osteoarthritis prevalence, the only patients benefiting from ACL-R were those undergoing concomitant meniscectomy with reconstruction.
OBJECTIVE: To determine the prophylactic capability of anterior cruciate ligament (ACL) reconstruction in decreasing the risk of knee osteoarthritis (OA) when compared with ACL-deficientpatients, as well as the effect of a concomitant meniscectomy. We also sought to examine the influence of study design, publication date, and graft type as well as the magnitude of change in physical activity from preinjury Tegner scores in both cohorts. DATA SOURCES: We searched Web of Science and PubMed databases from 1960 through 2012 with the search terms osteoarthritis, meniscectomy, anterior cruciate ligament, anterior cruciate ligament reconstruction, and anterior cruciate ligament deficient. STUDY SELECTION: Articles that reported the prevalence of tibiofemoral or patellofemoral OA based on radiographic assessment were included. We calculated numbers needed to treat and relative risk reduction with associated 95% confidence intervals for 3 groups (1) patients with meniscal and ACL injury, (2) patients with isolated ACL injury, and (3) total patients (groups 1 and 2). DATA EXTRACTION: A total of 38 studies met the criteria. Of these, 27 assessed the presence of tibiofemoral osteoarthritis in patients treated with anterior cruciate ligament reconstruction. DATA SYNTHESIS: Overall, ACL reconstruction (ACL-R) yielded a numbers needed to treat to harm of 16 with a relative risk increase of 16%. Anterior cruciate ligament reconstruction along with meniscectomy yielded a numbers needed to treat to benefit of 15 and relative risk reduction of 11%. Isolated ACL-R showed a numbers needed to treat to harm of 8 and relative risk increase of 43%. Activity levels were decreased in both ACL-R (d = -0.90; 95% confidence interval = 0.77, 1.13) and ACL-deficient (d = -1.13; 95% confidence interval = 0.96, 1.29) patients after injury. CONCLUSIONS: The current literature does not provide substantial evidence to suggest that ACL-R is an adequate intervention to prevent knee osteoarthritis. With regard to osteoarthritis prevalence, the only patients benefiting from ACL-R were those undergoing concomitant meniscectomy with reconstruction.
Authors: Letha Y Griffin; Marjorie J Albohm; Elizabeth A Arendt; Roald Bahr; Bruce D Beynnon; Marlene Demaio; Randall W Dick; Lars Engebretsen; William E Garrett; Jo A Hannafin; Tim E Hewett; Laura J Huston; Mary Lloyd Ireland; Robert J Johnson; Scott Lephart; Bert R Mandelbaum; Barton J Mann; Paul H Marks; Stephen W Marshall; Grethe Myklebust; Frank R Noyes; Christopher Powers; Clarence Shields; Sandra J Shultz; Holly Silvers; James Slauterbeck; Dean C Taylor; Carol C Teitz; Edward M Wojtys; Bing Yu Journal: Am J Sports Med Date: 2006-09 Impact factor: 6.202
Authors: Paul Neuman; Martin Englund; Ioannis Kostogiannis; Thomas Fridén; Harald Roos; Leif E Dahlberg Journal: Am J Sports Med Date: 2008-05-15 Impact factor: 6.202
Authors: Brian Pietrosimone; Richard F Loeser; J Troy Blackburn; Darin A Padua; Matthew S Harkey; Laura E Stanley; Brittney A Luc-Harkey; Veronica Ulici; Stephen W Marshall; Joanne M Jordan; Jeffery T Spang Journal: J Orthop Res Date: 2017-03-02 Impact factor: 3.494
Authors: Brian G Pietrosimone; Adam S Lepley; Hayley M Ericksen; Amy Clements; David H Sohn; Phillip A Gribble Journal: J Athl Train Date: 2015-04-06 Impact factor: 2.860
Authors: Sandra J Shultz; Randy J Schmitz; Kenneth L Cameron; Kevin R Ford; Dustin R Grooms; Lindsey K Lepley; Gregory D Myer; Brian Pietrosimone Journal: J Athl Train Date: 2019-08-28 Impact factor: 2.860
Authors: Christian Konrads; Stephan Reppenhagen; Daniel Belder; Sascha Goebel; Maximilian Rudert; Thomas Barthel Journal: Int Orthop Date: 2016-10-03 Impact factor: 3.075
Authors: Kurt P Spindler; Laura J Huston; Kevin M Chagin; Michael W Kattan; Emily K Reinke; Annunziato Amendola; Jack T Andrish; Robert H Brophy; Charles L Cox; Warren R Dunn; David C Flanigan; Morgan H Jones; Christopher C Kaeding; Robert A Magnussen; Robert G Marx; Matthew J Matava; Eric C McCarty; Richard D Parker; Angela D Pedroza; Armando F Vidal; Michelle L Wolcott; Brian R Wolf; Rick W Wright Journal: Am J Sports Med Date: 2018-03 Impact factor: 6.202